Public source

Reviewed 8 Oct 2026

Completeness Good (47%)

MRCAT Pelvis

Philips

MRCAT Pelvis supports MRI-only radiation therapy planning. A single MR examination provides soft-tissue contrast for target and organ-at-risk (OAR) delineation and continuous Hounsfield units for dose calculations. MRCAT (MR for Calculating ATtenuation) data can be exported to treatment planning systems for CT-equivalent dose calculations. The MR-based images also support CBCT-based patient positioning using soft-tissue contrast and a CT-like image appearance.

No papers to support — we monitor for new evidence.

Key features

MR-only workflow

Synthetic CT Generation

General Information

Product name

MRCAT Pelvis

Company

Workflow phase

Imaging

Modality

MR

Treatment site

Female pelvis, Male pelvis

Exact structures

Not specified

Regulatory Information

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

FDA Number:

Verified by Health AI Register

CE Certification

Pathway:

MDR

Class:

Class IIb

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Prerequisites

Specific hardware required

Defined prerequisite(s)

Compatibility MR systems: Ingenia 1.5T and 3.0T MR-RT, Ambition 1.5T MR-RT and Elition 3.0T MR-RT

Treatment technique

Not applicable

Delivery system

Not applicable

Workflow features

MR only

Patient population age

Adult

Input

3D mDIXON XD FFE with breathing compensation and powered by Compressed SENSE. This scan is standardized and fixed for consistent MRCAT generation results. 3D T2W TSE. For high resolution, anatomical information for delineation purposes, can be modified to match hospital preferences. Other sequences can be added to the protocol based on department’s needs

Input format

DICOM

Output

MRCAT images

Output format

Not specified

Integration

Embedded on the MR console

Integration method

Not specified

API documentation availability

Not specified

API documentation, if publicly available

Not specified

TPS compatibility

Vendor-neutral

Deployment

Not specified

Trigger for AI functionality

Not specified

Processing time

Not specified

Retraining locally

Not applicable

Claims

Not specified

Known limitations

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Oct 7, 2026 | Last updated: Oct 8, 2026